Log in to save to my catalogue

A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation

A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1b741caa0f3f47cf9906b953231ec886

A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation

About this item

Full title

A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation

Author / Creator

Publisher

London: BioMed Central Ltd

Journal title

BMC medical research methodology, 2022-10, Vol.22 (1), p.1-258, Article 258

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Current dose-finding designs for phase I clinical trials can correctly select the MTD in a range of 30-80% depending on various conditions based on a sample of 30 subjects. However, there is still an unmet need for efficiency and cost saving. Methods We propose a novel dose-finding design based on Bayesian stochastic approximation. The d...

Alternative Titles

Full title

A dose-finding design for phase I clinical trials based on Bayesian stochastic approximation

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1b741caa0f3f47cf9906b953231ec886

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1b741caa0f3f47cf9906b953231ec886

Other Identifiers

ISSN

1471-2288

E-ISSN

1471-2288

DOI

10.1186/s12874-022-01741-3

How to access this item